Development of a 99mTc-Labeled CXCR4 Antagonist Derivative as a New Tumor Radiotracer

Cancer Biotherapy & Radiopharmaceuticals , Vol. 0, No. 0.


from Mary Ann Liebert, Inc. publishers via xlomafota13 on Inoreader http://ift.tt/2nAAWS5
via IFTTT